About us
GAMA Healthcare is a dynamic, innovative company at the forefront of infection prevention technology. We specialise in the manufacture and distribution of revolutionary IPC products and the provision of exceptional aftercare support.
Since we launched as a company in 2004, we have been on an exciting whirlwind of a journey...
What we do
Infection prevention
Research & development
Training
Business support
Our offices
UK Head Office
Located in Watford, Hertfordshire, our modern, open-plan style facilitates collaboration across all departments.
Fellows Research Centre
Our brand new 14,000sq ft laboratory in Halifax conducts cutting-edge research, driving the development of evermore innovative GAMA products.
Australia HQ
Our friendly and welcoming Australian office solidifies GAMA’s position as a global infection prevention company.
Responsibility at GAMA
Infection prevention means caring for others. Everything we do is guided by the desire to keep patients safe and leave a positive impact on our world.
Find out moreOur team
Meet GAMA Healthcare's dedicated leadership team
Dr Guy Braverman - Managing Director & Co-Founder
Utilising his medical experience, Guy saw a need for better infection prevention solutions to keep patients safe, founding GAMA in 2004.
Dr Allen Hanouka - Managing Director & Co-Founder
Working as a doctor, Allen experienced firsthand the unfulfilled needs within infection prevention, directly leading him to co-found GAMA.
Phil Johnson – New Product Development Director
Phil excels in disruptive scientific innovation. His unique vision helps drive our consumer-led R&D projects to market.
Careers
At GAMA, we offer a range of exciting career paths. Our employees are valued and given the opportunity to develop their skills in an inspiring, collaborative atmosphere.
Join our teamLatest
The biofilm challenge for cleaning, disinfection, and sterilisation
In the AJIC special issue on ‘Disinfection, sterilization, and antisepsis’, there is a helpful State-of-the-Science mini-review on the importance of biofilms in medical device reprocessing and healthcare surface disinfection.
Is there a relationship between biocide use and antimicrobial resistance?
The next article in the AJIC special issue on ‘Disinfection, sterilization, and antisepsis’ is a mini-review on whether there is a relationship between biocide use and antimicrobial resistance. Reassuringly, despite the widespread use of biocides in healthcare settings (and in consumer markets), acquired resistance has rarely been reported.
AJIC special issue on cleaning, disinfection, antisepsis and sterilisation
The American Journal of Infection Control has recently published a must-read special issue titled: ‘Disinfection, sterilization, and antisepsis: Principles, practices, current issues, new research, and new technologies.’